NGM BIOPHARMACEUTICALS INC Accounts Payable
NGM BIOPHARMACEUTICALS INC had Accounts Payable of $2.98 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-03-11
- 2023-12-31: Accounts Payable, Current $2.98M.
- 2023-09-30: Accounts Payable, Current $4.69M.
- 2023-06-30: Accounts Payable, Current $5.86M.
- 2023-03-31: Accounts Payable, Current $13.29M.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-12-31 | $2.98M 10-K · filed 2024-03-11 |
| 2023-09-30 | $4.69M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $5.86M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $13.29M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.45M 10-K · filed 2024-03-11 |
| 2022-09-30 | $3.56M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.87M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.82M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.25M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.63M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.14M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $7.54M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.66M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.61M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.93M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $3.65M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $9.03M 10-K · filed 2021-03-15 |
| 2019-09-30 | $4.46M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.16M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $4.20M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $5.78M 10-K · filed 2020-03-17 |